Silver Book Fact

The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.

Day S, Acquah K, Lee P, Mruthyunjaya P, et al. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
2011
Authors
Day S, Acquah K, Lee P, Mruthyunjaya P, et al.
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • The average cost in 2004 per glaucoma patient age 40 to 64 using outpatient services was $276. The average cost per patient 54 years and older was $254.  
  • The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually–…  
  • Quality of Life Impact Top Concern from Vision Loss Among Individuals Polled
    “Quality of life” ranked as top concern by non-Hispanic Whites (73%), and Asians (68%)–when asked to consider various possible consequences of vision loss.  African Americans (66%) and Hispanics (63%) ranked…  
  • Based on estimates from 1997 data, around 115,583 visually impaired and 74,133 blind individuals who did not work, would have worked if they had been fully sighted.  
  • Currently an estimated 38 million Americans suffer from blindness, low vision, or an age-related eye disease. That number is expected to grow to around 50 million by 2020.